This audiobook overview is an accompaniment to the e-book Transforming Pharmaceuticals with XR and Digital Twins

Transforming Pharmaceuticals with XR and Digital Twins

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss why seemingly routine comments from Vinay Prasad, director of the US Food and Drug Administration’s Center for Biologics Evaluation and Research, that he would stay away from daily review decisions were notable (:26), as well as the impact of proposed FDA budget cuts by the White House and the House of Representatives (17:16).

More On These Topics From The Pink Sheet

Prasad Says Involvement In US FDA Product Approvals Will Mirror Prior CBER Directors: https://insights.citeline.com/pink-sheet/rare-diseases/prasad-says-involvement-in-us-fda-product-approvals-will-mirror-prior-cber-directors-KF4LJWX5U5DLBMSM6D4YFL7ZOA/ 

To Compete With China, US FDA Must Deregulate Early Gene Therapy Studies, CAR-T Inventor Says: https://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/to-compete-with-china-us-fda-must-deregulate-early-gene-therapy-studies-car-t-inventor-says-VDVXZGZIJZFHHNGGQXYILBI7RM/ 

FDA’s FY 2026 Budget Request Lacks New Policy Proposals: https://insights.citeline.com/pink-sheet/legislation/fdas-fy-2026-budget-request-lacks-new-policy-proposals-WV3LE2AYBRAC7LIYJEU4WZDNGU/ 

User Fee-Funded Staff Would Drop In FY 2026 US FDA Budget: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/user-fee-funded-staff-would-drop-in-fy-2026-us-fda-budget-TQZMEB57V5GELNPMYGTY5BEGOY/ 

House Gives US FDA More Non-User Fee Funds Than Requested: https://insights.citeline.com/pink-sheet/pathways-and-standards/user-fees/house-gives-us-fda-more-non-user-fee-funds-than-requested-PCQZCBHOB5ARPICMJJQ6VYIJ5M/

Drug Fix: Prasad Staying Out Of Application Reviews, US FDA Proposed Budget Cuts

[REUPLOAD W/FIXED PEAKING ISSUE]
This is the version and/or volume 2 of the Pharmaceuticals OST! Includes V1 as well :3

Official pre-order

MISSING PERSON | Nilson Chase Theme

DESERTER | Nilson / Vladimir Last Man Standing

DESERTER NO MORE | Nilson / Vladimir Last Man Standing | Milestone 3-4

CLEAR ALERT | Nilson Chase Theme | Milestone 3-4

MISSING PERSON - Nilson Milestone 3-4 Chase Theme

DESERTER NO MORE - Nilson Milestone 3-4 v. Vladimir Milestone 3-4 Last Man Standing

MISSING PERSON - Nilson Chase Theme

DESERTER - Nilson v. Vladimir Chase Theme Last Man Standing

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

About Pharma. [WT] OST 2:
FL glitched on the vocal samples :(

Hello! I’m Coto. There’s nothing to take out of context here because there’s no context! Yeah, I make music sometimes. Don’t expect anything professional. See y’all soon!

QnA

Q: Opinion on Deltaru-
A: SPAMTON

Q: Opinion on the Russian-Ukrainian war?
A: Go Ukraine!

Q: What's your release schedule?
A: I do not currently have one, but would like to try to start uploading more frequently. I am very close to 100 followers!

Q: What do you do when you run into a furry hater?
A: I personally still try to give them respect, and usually will just say "Ok, cool."

Q: What's up with the constant name changes?
A: Was never able to decide on my name here on SoundCloud. Until now, that is.

If you want me to add anything here, as I said, just DM me!

Info:

Discord: Lol removing cuz of spam bots :>

Also, just a thing: Disco Polo needs more attention in the US.
Its disco music but from Poland
Also it has an accordian.
I love this so much-

New tracks tagged #pharmaceuticals